tiprankstipranks
Advertisement
Advertisement

ANGO Stock Latest News

AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
Company AnnouncementsAngioDynamics Files Patent Suit to Protect Thrombectomy Technology
14d ago
8K
ANGO
AngioDynamics initiated with a Buy at Freedom Broker
PremiumThe Fly
AngioDynamics initiated with a Buy at Freedom Broker
1M ago
ANGO
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
PremiumRatings
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
1M ago
ANGO
AngioDynamics price target lowered to $16 from $18 at Canaccord
PremiumThe Fly
AngioDynamics price target lowered to $16 from $18 at Canaccord
1M ago
ANGO
AngioDynamics Earnings Call Highlights Med Tech Momentum
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights Med Tech Momentum
1M ago
ANGO
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
PremiumThe FlyMidday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
1M ago
F
BP
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
Premium
Company Announcements
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
1M ago
8K
ANGO
Options Volatility and Implied Earnings Moves Today, April 02, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, April 02, 2026
1M ago
AYI
LNN
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
PremiumThe Fly
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
1M ago
ANGO
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
PremiumThe Fly
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
1M ago
ANGO
AngioDynamics Targets High‑Risk Limb Ischemia With New Auryon Trial in Europe
PremiumCompany Announcements
AngioDynamics Targets High‑Risk Limb Ischemia With New Auryon Trial in Europe
2M ago
ANGO
AngioDynamics Targets Growth In Clot Treatment With New Pulmonary Embolism Study
PremiumCompany Announcements
AngioDynamics Targets Growth In Clot Treatment With New Pulmonary Embolism Study
3M ago
ANGO
AngioDynamics announces CEO transition and leadership retention plan
PremiumCompany AnnouncementsAngioDynamics announces CEO transition and leadership retention plan
3M ago
8K
ANGO
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
Premium
Company Announcements
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
4M ago
8K
ANGO
AngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
Premium
Ratings
AngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
4M ago
ANGO
AngioDynamics Earnings Call Highlights Med Tech Momentum
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights Med Tech Momentum
4M ago
ANGO
Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
PremiumThe Fly
Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
4M ago
E
ET
AngioDynamics posts strong Q2 results, raises 2026 outlook
PremiumCompany Announcements
AngioDynamics posts strong Q2 results, raises 2026 outlook
4M ago
8K
ANGO
Options Volatility and Implied Earnings Moves Today, January 06, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, January 06, 2026
4M ago
AIR
ANGO
AngioDynamics says still expects to be cash flow positive for FY26
PremiumThe FlyAngioDynamics says still expects to be cash flow positive for FY26
4M ago
ANGO
AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)
Premium
The Fly
AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)
4M ago
ANGO
AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)
Premium
The Fly
AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)
4M ago
ANGO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >